Purpose: To determine the in vivo efficacy of cyclosporine A-loaded solid lipid nanoparticles (SLNs) in rabbit eyes.

Methods: SLNs were prepared and administered to the cul-de-sac of rabbits, and the drug amount in aqueous humor was detected by high performance liquid chromatography (HPLC). The irritation was evaluated by modified Draize testing.

Results: The particle size of SLNs was detected as 225.9 +/- 5.5 nm with a negative surface charge. Aqueous humor drug levels reached 50.53 ng/mL, and there was no serious irritation in rabbit eyes.

Conclusions: Topical ophthalmic efficacy of cyclosporine A was enhanced via administration of SLNs.

Download full-text PDF

Source
http://dx.doi.org/10.3109/02713680903261405DOI Listing

Publication Analysis

Top Keywords

cyclosporine a-loaded
8
a-loaded solid
8
solid lipid
8
lipid nanoparticles
8
efficacy cyclosporine
8
aqueous humor
8
nanoparticles ocular
4
ocular tolerance
4
tolerance vivo
4
vivo drug
4

Similar Publications

Meibomian gland dysfunction (MGD) and dry eye syndrome (DES) are common eye diseases characterized by altered tear film stability and inflammation of the ocular surface, causing significant discomfort and possible visual impairment. This study aimed to investigate the efficacy of curcumin-loaded liposomes (Lipo@Cur) compared to cyclosporine A-loaded liposomes (Lipo@CycA) in experimental rabbit models of MGD and DES, with a focus on their ability to improve tear film stability and reduce ocular surface inflammation. MGD and DES were induced using complete Freund's adjuvant (CFA) and treated to evaluate the effect of liposomal formulations on tear break-up time (TBUT), clinical signs of inflammation (telangiectasia, conjunctival hyperemia, meibomian foramen occlusion), and corneal as well as conjunctival histological cells.

View Article and Find Full Text PDF

Integrin α4β1 and α4β7 are overexpressed in macrophages and leukocytes and play important roles in mediating cell homing and recruitment to inflammatory tissues. Herein, to enhance the targeting ability of nanotherapeutics for inflammatory bowel disease (IBD) treatment, cyclosporine A-loaded nanoparticles (CsA NPs) were coated with macrophage membranes (MM-CsA NPs) or leukocyte membranes (LM-CsA NPs). In vitro experiments demonstrated that the physicochemical properties of the nanotherapeutics (e.

View Article and Find Full Text PDF
Article Synopsis
  • The research investigates whether combining cyclosporine A (CsA) and voriconazole (VRZ) in nanocarriers enhances their antifungal effect compared to using them separately.
  • The study prepared and characterized various polymer-based nanoparticles, concluding that VRZ-loaded PLGA nanoparticles did not significantly enhance antifungal activity compared to free VRZ, but the combined VRZ and CsA in PLGA NPs exhibited a fourfold increase in synergistic action.
  • Additionally, while high concentrations of blank PLGA nanoparticles inhibited C. albicans biofilm formation, lower concentrations showed little effect, suggesting that encapsulation of CsA and VRZ leads to more effective biofilm inhibition than when the drugs are free.
View Article and Find Full Text PDF

Purpose: Dry eye syndrome (DES), arising from various etiologic factors, leads to tear film instability and ocular surface damage. Given its anti-inflammatory effects, cyclosporine A (CsA) has been widely used as a short-term treatment option for DES. However, poor bioavailability and solubility of CsA in aqueous phase make the development of a cyclosporine A-based eye drop for ocular topical application a huge challenge.

View Article and Find Full Text PDF

Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model.

Drug Deliv Transl Res

December 2024

Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Ave. Vicent Andrés Estellés s/n, 46100, Burjassot, Valencia, Spain.

Several drugs can be used for treating inflammatory skin pathologies like dermatitis and psoriasis. However, for the management of chronic and long-term cases, topical administration is preferred over oral delivery since it prevents certain issues due to systemic side effects from occurring. Cyclosporin A (CsA) has been used for this purpose; however, its high molecular weight (1202 Da) restricts the diffusion through the skin structure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!